Weight Loss Drugs May Risk Bone Health and Malnutrition

from TheBrief.Health · host TheBrief.Health

Rising use of semaglutide and tirzepatide highlights risks of malnutrition and bone loss, prompting clinicians to monitor nutrition, especially in vulnerable populations.

Episode metadata supplied by the publisher feed · Published Apr 23, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Weight Loss Drugs May Risk Bone Health and Malnutrition

0:00 1:27

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TheBrief.Health?

This episode is 1 minute long.

When was this TheBrief.Health episode published?

This episode was published on April 23, 2026.

Can I download this TheBrief.Health episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!